Biolinq is pioneering a revolutionary platform in metabolic health through advanced biowearable technology. Their innovative biosensing platform reimagines health monitoring by sensing analytes just below the surface of the skin using an array of ultra-small electrochemical sensors. This technology offers real-time feedback derived from multiple sensors, providing accurate and reliable continuous health insights.

With over 120 million dollars invested and more than 500,000 hours of clinical data, Biolinq is at the forefront of biowearable innovation. Their platform is designed to sense multiple analytes, enhancing personalized medicine possibilities and metabolic health insights. Their team of industry experts leverages extensive experience in biosensor manufacturing and proprietary design to scale their biowearable products with comfort and performance in mind.